Desmopressin

From WikiMD's WELLNESSPEDIA

(Redirected from Desmopressin acetate)

Desmopressin is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is primarily used in the management of Central Diabetes Insipidus, for the treatment of Nocturnal Enuresis (bedwetting), and in the treatment of von Willebrand's Disease and mild Hemophilia A. Desmopressin works by limiting the amount of water that is eliminated in the urine.

Medical Uses[edit]

Desmopressin is used in the treatment of:

Mechanism of Action[edit]

Desmopressin acts on the V2 receptors in the renal collecting ducts, leading to the translocation of aquaporin-2 water channels to the apical membrane of the cells and thereby increasing water reabsorption. In patients with bleeding disorders, desmopressin stimulates the release of von Willebrand factor and factor VIII stored in the endothelium, which helps in controlling bleeding.

Administration[edit]

Desmopressin can be administered intranasally, orally, or by subcutaneous or intravenous injection. The mode of administration depends on the condition being treated and the patient's needs.

Side Effects[edit]

Common side effects of desmopressin include headache, facial flushing, nausea, and abdominal cramps. Severe side effects may include hyponatremia (low sodium levels), which can lead to seizures if not properly managed.

Contraindications[edit]

Desmopressin is contraindicated in individuals with:

  • Hyponatremia or a history of hyponatremia.
  • Severe renal impairment.
  • Uncontrolled hypertension.
  • Known hypersensitivity to desmopressin or any of its components.

Pharmacokinetics[edit]

Desmopressin has a half-life of approximately 1.5 to 2.5 hours, with variations depending on the route of administration. Its effects on the kidneys can last up to 8 hours, while its effects on clotting factors can last up to 24 hours.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.